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Abstract Phosphatidylserine (PS) exposure in red blood cells
(RBCs) from sickle cell disease (SCD) patients is increased
compared to levels in normal individuals and may participate
in the anaemic and ischaemic complications of SCD. Expo-
sure is increased by deoxygenation and occurs with elevation
of intracellular Ca2+ to low micromolar levels. The Ca2+ entry
step has not been defined but a role for the deoxygenation-
induced pathway, Psickle, is postulated. Partial Psickle in-
hibitors 4-acetamido-4′-isothiocyanostilbene-2,2′-disulphonic
acid (SITS), 4,4′-dithiocyano-2,2′-stilbene-disulphonic acid
(DIDS) and dipyridamole inhibited deoxygenation-induced
PS exposure (DIDS IC50, 118 nM). Inhibitors and activators
of other pathways (including these stimulated by
depolarisation, benzodiazepines, glutamate and stretch) were
without effect. Zn2+ and Gd3+ stimulated PS exposure to high
levels. In the case of Zn2+, this effect was independent of
oxygen (and hence HbS polymerisation and RBC sickling)
but required extracellular Ca2+. The effect was completely
abolished when Zn2+ (100μM)was added to RBCs suspended
in autologous plasma, implying a requirement of high levels of
free Zn2+.
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Introduction
Phosphatidylserine (PS) is an aminophospholipid which is
normally confined to the inner leaflet of lipid bilayers [40].
In red blood cells (RBCs), this is particularly important
because its exposure is prothrombotic, encourages phagocy-
tosis and increases RBC adherence [7, 29, 59, 63, 64]. In
healthy individuals, usually <1 % RBCs expose PS [40].
Programmed externalisation is thought to occur in damaged
or senescent RBCs to aid their removal from the circulation.
This process has been termed eryptosis [42, 45] and is
analogous to the apoptosis of nucleated cells. Elevated PS
exposure is also seen in a number of disease states, including
sickle cell disease (SCD) [17, 66].
In SCD, patients show various complications which fall
into two main groups: a chronic anaemia and acute vaso-
occlusive disorders (such as pain, stroke, acute chest syn-
drome and osteonecrosis). PS exposure is observed in a high,
but variable, percentage of RBCs (2–10 % is often quoted
[15, 17, 40, 41, 66, 67]). PS may therefore contribute to both
the anaemic and ischaemic complications of SCD [29]. The
mechanism by which it becomes externalised has therefore
received considerable attention [1, 17, 40].
Asymmetrical distribution of PS is usually maintained by
high activity of an ATP-dependent aminophospholipid
translocase (or flippase) in conjunction with relatively
low activity of a Ca2+-activated scrambling process (or
scramblase activity) [4, 25]. The presence of the abnormal
haemoglobin, HbS, in patients’ RBCs somehow perturbs this
equilibrium to favour PS exposure. HbS molecules are able to
aggregate on deoxygenation forming rigid polymers which
distort RBC shape, alter rheology and stimulate a number of
other deleterious sequelae [29]. Deoxygenation also stimu-
lates PS exposure [6, 49, 66]. Damage to the cytoskeleton may
free PS from anchor sites resulting in its higher mobility [22,
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26, 52]. In addition, however, deoxygenation-induced PS
exposure is Ca2+ dependent requiring elevation of the concen-
tration of intracellular Ca2+ ([Ca2+]i) to low micromolar levels
[66]. The high cation permeability of HbS-containing RBCs
may be involved in this process [24, 31, 46]. In particular, a
role has been postulated for the deoxygenation-induced cation
conductance (sometimes termed Psickle) which is activated
upon deoxygenation, HbS polymerisation and RBC shape
change [32, 46, 50]. This pathway is permeable to divalent
cations including Ca2+ and can therefore mediate Ca2+ entry.
Elevated [Ca2+]i both inhibits the flippase and also activates
the scramblase [25]. A number of other RBC cationic perme-
abilities have also been described, however, including con-
ductances activated by depolarisation, glutamate, benzodiaz-
epines and stretch, as well as following infection with
intraerythrocytic parasites like malaria [3, 35] (although the
latter is more widely considered to increase activity of anion-
selective pathways [39]). One or more of these, instead of, or
as well as Psickle, may contribute to the Ca
2+ entry involved in
deoxygenation-induced PS exposure. Clear identification of
the pathway(s) involved would be beneficial as it would direct
the search for potential inhibitors amenable to clinical use for
amelioration of the complications of SCD.
In this study, we use various inhibitors and agonists of
RBC pathways in an attempt to clarify the Ca2+ entry step
which results in deoxygenation-induced PS exposure in
RBCs from SCD patients. Results indicate that partial inhib-
itors of Psickle reduced deoxygenation-induced PS exposure,
consistent with mediation of Ca2+ entry via this pathway, but
those inhibitors and activators of several other potential entry
pathways were without effect.
Materials and methods
Solutions and chemicals
The main experimental saline comprised (in millimolar): NaCl
140, KCl 4, CaCl2 1.1,MgCl2 0.15,N-2-hydroxyethylpiperzine-
N′-2-ethanesulphonic acid (HEPES) 10 and inosine 10 with
a pH of 7.4 at 37 °C (low potassium-containing saline, LK
HBS). For washing red blood cells (RBCs), a high potassium-
containing saline (HK HBS) was usually used, comprising (in
millimolar) NaCl 54, KCl 90, MgCl2 0.15, HEPES 10 and
inosine 10 with a pH of 7.4 at room temperature. For exper-
iments carried out in plasma, the RBC wash solution com-
prised NaHCO3 24 mM and NaCl 137 mM equilibrated with
air and 5 % CO2, pH 7.4. The ice-cold wash solution for K
+
flux measurements comprised (in millimolar) MgCl2 107,
3-(N-morpholino)-propanesulphonic acid (MOPS) 10, pH
7.4 at 0 °C. Fluorescein isothiocyanate-conjugated lactadherin
(LA-FITC)-binding buffer consisted of LK HBS with 1 mM
vanadate and 16 nM LA-FITC. Osmolality of all solutions
was 290±5 mOsm kg−1. LA-FITC was obtained from
Haematologic Technologies Inc. (VT, USA) supplied via
Cambridge Bioscience (Cambridge, UK), phycoerythrin
(PE)-conjugated anti-glycophorin A from Becton Dickinson
Biosciences (CA, USA), HEPES and 4,4′-dithiocyano-2,2′-
stilbene-disulphonic acid (DIDS) from Calbiochem (Merck,
Darmstadt, Germany) and 86Rb+ from PerkinElmer (MA,
USA). Diazepam and PK11195 were gifts fromDr. Guillaume
Bouyer (CNRS, Roscoff, France). All other chemicals came
from Sigma-Aldrich (Poole, Dorset, UK).
RBC preparation
Blood samples were collected from HbSS SCD patients, with
consent and ethical permission (11/LO/0065), in the anticoag-
ulant EDTA, except for the experiments in which RBCs were
incubated in autologous plasma. In this case, heparin was used
as an anticoagulant to prevent chelation of Ca2+ and/or Zn2+
(Fig. 6). In Fig. 6, only RBCs from normal (HbAA) individuals
were used. RBCs were washed three times into HK HBS for
3 min at 600 g and then subsequently twice into LK HBS,
unless otherwise indicated, to give a final haematocrit (Hct) of
5 %. RBC suspensions were then deoxygenated for 20 min in
Eschweiler tonometers flushed with warmed humidified N2, by
which time PS exposure was unchanged relative to that mea-
sured in untreated RBCs (as shown previously [66]). They
were then diluted into test tubes also pre-equilibrated with N2
(final Hct 0.5 %) in the absence or presence of potential
inhibitors/activators of PS exposure. Incubation was carried
out at 37 °C for up to 60 min in the presence of 1 mM vanadate
to inhibit both the flippase and the plasma membrane calcium
pump. Solutions of DIDS (stock 5–50 mM in DMSO) were
made up fresh every other day as stability decreased after 3 days
resulting in strong stimulation of PS exposure, probably
through the action of a breakdown product(s). Controls were
exposed to the same final concentration of solvent (DMSO or
H2O, 0.2 %) but otherwise treated in the same way. For exper-
iments with glutamate receptor agonists, N-methyl-D-aspartate
(NMDA) and homocysteine, RBCs were kept oxygenated and
incubated in Eppendorf tubes (up to 60 min, 37 °C). For
experiments to test the effect of plasma on the action of Zn2+,
RBCs were re-suspended in autologous plasma after washing,
equilibrated with air and 5 % CO2 delivered using a Wösthoff
gas mixer (Bochum, Germany) at 37 °C to give a final pH 7.4.
Normal total plasma Zn2+ levels are about 10–15 μM [16, 28,
48]. This was not measured, rather additional Zn2+ at the
concentration indicated was added directly to plasma and thus
represented the minimum total concentration present.
Labelling of PS exposure
Samples of 5 μl aliquots (105 RBCs) were placed in 250 μl
of LA-FITC binding buffer. PS labelling was carried out in
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the dark, because of the high sensitivity of FITC to light, at
room temperature for 10 min. RBCs were then pelleted by
centrifugation for 10 s at 16,100×g and washed once into LK
HBS to remove unbound LA-FITC. Unlike annexin-V, LA-
FITC binds to PS in a Ca2+-independent manner [14, 61].
Control experiments showed that binding was irreversible.
Samples were then kept on ice until analysed by flow cy-
tometry (FACS). Inhibitors/activators were tested (at
100 μM) for self-fluorescence using unlabelled RBCs. The
percentage of RBCs exposing PS is usually normalised to
values measured in control RBCs prior to addition of in-
hibitors, as the absolute magnitude of exposure varied be-
tween samples. These control values are given in the figure
legends.
FACS acquisition and analysis
Externalised PS was measured in the FL-1 channel, with an
emission wavelength for FITC of 519 nm, of a fluorescence-
activated flow cytometer (FACSCalibur, Becton Dickinson,
BD) and analysed with BD CellQuest Pro software using the
protocol as previously published [66]. In control experi-
ments, forward scatter (FSC, size) and side scatter (SSC,
granularity) gates for RBCs were identified using a PE-
labelled anti-glycophorin A assay. FSC was set with thresh-
old at 512. Measurements were taken under logarithmic gain
with voltages set at FSC, E00; SSC, 235; FL-1, 688; FL-2,
630; and FL-3, 590. Compensation was set as FL-1, 2.0 % of
FL-2; FL-2, 19.6 % FL-1; FL-2, 0.0 % FL-3; and FL-3,
8.5 % FL-2 to minimise the effect of over spill of fluores-
cence to adjacent channels. For each measurement 10,000
events were gated. All gated LA-FITC-labelled cells were
additionally cross checked against overlap into FL-2 and FL-
3 fluorescent channels and for spill out of the size gate and if
these occurred events were excluded from analysis. The
percentage of such resolved events was noted and for most
experiments was ≤1 %. On FL-1/FL-2 dot plot graph, the
cut-off quadrants, for negative fluorescent gate, were set
using unlabelled cells as x=20 and y=20. The PS-positive
cells were represented as the percentage of all gated RBCs
with sufficient externalised PS to appear positive fluores-
cently in the FL-1 channel [14] and thus fallen into the
quadrant (x>20 and y<20).
K+ flux measurements
Potassium fluxes were measured using 86Rb+ as a tracer for
K+ [18, 62]. In these experiments, RBCs (Hct about 20 %)
were first equilibrated in Eschweiler tonometers (Kiel, Ger-
many) in air or N2 at 37 °C, pH 7.4, in LK saline in which Cl
−
was substituted with NO3
− and MOPS for HEPES. Cl−
substitution prevented K+ transport through the Na+-K+-
2Cl− cotransporter and K+-Cl− cotransporter. Aliquots were
then diluted tenfold into test tubes containing the same saline
and also pre-equilibrated with air or N2 for flux measure-
ments. Bumetanide (10 μM), ouabain (100 μM) and clotri-
mazole (5 μM) were all also present to inhibit K+ transport
through the Na+-K+-2Cl− cotransport, Na+/K+ pump and
Ca2+-activated K+ channel. 86Rb+ was then added into a
KCl solution to give a final [K+] of 7.5 mM. Influx was
performed over 10 min, after which RBCs were washed four
times in ice-cold isotonic MgCl2 wash solution, lysed using
Triton X-100 (0.1 %) and protein was precipitated with
trichloroacetic acid (5 %) and 5 min centrifugation at
13,000×g. 86Rb+ (K+) in the supernatant was then counted
by liquid scintillation as Čerenkov radiation (Tri-Carb
2100TR, PerkinElmer, MA, USA). The difference in K+
influx at the two gas tensions provides a measure of the
deoxygenation-induced cation conductance, Psickle.
RBC morphology
Suspensions of RBCs (0.2 % Hct) were fixed in saline in the
presence of glutaraldehyde (0.3 %) and viewed under a phase
field mode on Leica DM6000B Microscope (Leica
Microsystems Ltd, UK). From each sample, at least eight
different frames (×20) were saved using a digital camera
(AF600DFC) and Leica LAS AF Lite software to determine
the percentage of sickled cells. At least 500 cells were
counted for each sample.
Statistics
Unless otherwise indicated, data are presented as means ±
S.E.M. for n individuals. Statistical significance was tested
with paired Student’s t test; p<0.05 was accepted as signif-
icant. All graphs were made using GraphPad Prism 5 (San
Diego, CA). Samples from at least five individuals were
collected for each of experiments. Calculations were made
either using Microsoft Office Professional 2010 Excel soft-
ware or GraphPad Prism 5.
Results
Effect of oxygen tension on PS exposure in RBCs from SCD
patients
In control experiments, PS exposure in RBCs from SCD
patients was 3.3±0.2 % at time 0, increasing after deoxygen-
ation for 30 and 60 min to 7.5±0.4 and 10.5±0.6 % (means ±
S.E.M., n=124), respectively. The lowest PS exposure
values were 0.5, 1.7 and 1.9 % at time 0 and after 30 and
60 min deoxygenation, respectively, while the highest values
were 14.3, 27.5 and 26.2 %. In separate experiments, PS
exposure in RBCs kept oxygenated did not change
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(3.1±0.5 % at time 0 and 3.8±0.7 and 4.1±0.6 % after 30
and 60 min of incubation, respectively, n=13). We have
previously reported similar findings [66].
Effects of inhibitors of Psickle
Although there are no specific inhibitors of Psickle, stilbenes
[30] and the pyrimidine derivative dipyridamole [33] have
been shown to inhibit the deoxygenation-induced cation
permeability of RBCs from SCD patients. In the first series
of experiments, therefore, the effects of 4-acetamido-4′-
isothiocyanostilbene-2,2′-disulphonic acid (SITS), 4,4′-
dithiocyano-2,2′-stilbene-disulphonic acid (DIDS) and
dipyridamole were tested on deoxygenation-induced PS ex-
posure (Fig. 1). Each of the three reagents significantly
inhibited the deoxygenation-induced PS exposure at both
30 and 60 min, at all concentrations used (10, 50 and
100 μM). The effect of DIDS was explored in more detail.
Significant inhibition was observed by 100 nM (p<0.005),
with an IC50 of 118±10 nM (n=9), and was largely complete
by 250 nM.
It was possible that these reagents acted indirectly through
inhibition of HbS polymerisation and sickling. This was
tested using morphological studies to assess the percentage
of RBCs which underwent sickling following deoxygen-
ation. After 60 min deoxygenation, in the absence and pres-
ence of DIDS (100 μM), sickling was 61±8 and 62±5 %
(means ± S.E.M., n=4, not significant (N.S.)), respectively.
A possible explanation for the effect of DIDS on PS expo-



























































































Fig. 1 Effect of Psickle inhibitors on deoxygenation-induced
phosphatidylserine (PS) exposure in red blood cells (RBCs) from
SCD patients. a PS exposure is normalised to exposure in RBCs at time
0, just before addition of SITS, which was 2.8±0.8 % (indicated by the
dotted line), and after 30 and 60 min deoxygenation in the absence
(solid black histograms) or presence (lighter histograms) of SITS at 10,
50 and 100 μM. Data represent means ± S.E.M., n=5. *p<0.05 com-
pared to deoxygenated RBCs in the absence of SITS. b PS exposure is
normalised to exposure in RBCs at time 0, just before addition of DIDS,
which was 4.3±0.5 % (indicated by the dotted line), and after 30 and
60 min deoxygenation in the absence (solid black histograms) or
presence (lighter histograms) of DIDS at 10, 50 and 100 μM. Data
represent means ± S.E.M., n=8. *p<0.002 compared to deoxygenated
RBCs in the absence of DIDS. Inset represents the concentration
dependence of DIDS inhibition of deoxygenation-induced PS exposure
in RBCs from SCD patients. Percentage PS exposure is shown after
60 min deoxygenation in RBCs treated with DIDS at the concentrations
indicated. PS exposure at time 0, just before addition of DIDS, was
4.8±0.7 %. IC50 for DIDS was 118±10 nM. Data represent means ±
S.E.M., n=9. c PS exposure is normalised to exposure in RBCs at time
0, just before addition of dipyridamole, which was 3.8±0.4 % (indicat-
ed by the dotted line), and after 30 and 60 min deoxygenation in the
absence (solid black histograms) or presence (lighter histograms) of
dipyridamole at 10, 50 and 100 μM. Data represent means ± S.E.M.,
n=7. *p<0.02 compared to deoxygenated RBCs in the absence of
dipyridamole
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Effect of inhibitors of the non-specific cation channels
of RBCs
A non-selective cation conductance has been described in
RBCs from normal individuals, activated by a number of
manoeuvres including osmotic or oxidative shock, or Cl−
substitution with gluconate (which will also cause RBC
shrinkage) [19, 43]. Amiloride derivatives represent effec-
tive inhibitors of this pathway [44]. The effect of
ethylisopropylamiloride (EIPA) was therefore tested on the
deoxygenation-induced PS exposure of RBCs from patients
with SCD but no significant effect was observed (Fig. 2).
Effects of inhibitors of unusual RBC cation pathways
Recently, it has been proposed that RBCs express a conduc-
tance mediated via the peripheral benzodiazepine receptor
(PBR) [9]. This pathway has multiple conductance states and
is permeable to a number of ions including anions. It has also
been postulated that RBCs respond to glutamate receptor
agonists, such as NMDA and homocysteine, with the possi-
bility that these ligand-gated channels may also be present
[51]. Various agonists and antagonists of these pathways were
investigated (Fig. 3). In experiments on deoxygenation-
induced PS exposure, however, neither the PBR agonist diaz-
epam (10–100 μM; Fig. 3a) nor its antagonist PK11195 (10–
100 μM; Fig. 3b) had any significant effects. When tested on
oxygenated RBCs, the glutamate receptor agonists NMDA
and homocysteine (both 100 μM; Fig. 3c) did not affect PS
exposure. Similarly, the NMDA receptor antagonist (+)-5-
methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-im-
ine hydrogen maleate (MK-801, 50 μM) had no effect on the
deoxygenation-induced PS exposure (data not shown).
Effects of inhibitors of stretch-activated channels
Under certain conditions, the aminoglycoside antibiotics,
streptomycin and gentamicin [13], and the heavy metals
Zn2+ and Gd3+ [10, 13, 50] reduce the permeability of RBCs
from SCD patients, possibly acting as stretch-activated chan-
nel blockers [60]. Long-term treatment with Zn2+ has also
been observed to induce PS exposure in normal human
RBCs [38]. Their effects on deoxygenation-induced PS ex-
posure were investigated (Figs. 4 and 5). In the presence of
streptomycin, PS exposure increased, but not significantly
(Fig. 4).
Both Zn2+ (up to 100 μM) and Gd3+ (up to 50 μM)
markedly increased PS exposure (Fig. 5a, b). Higher con-
centrations of Gd3+ (100 μM) caused RBC aggregation and
its effects could not be investigated using FACS. The action
of Zn2+ (100 μM) was studied in more detail (Table 1). Zn2+
significantly increased PS exposure in both oxygenated and
deoxygenated RBCs. Its effect was therefore different to the
deoxygenation-induced PS exposure, requiring HbS poly-
merisation and sickling. The effect, however, was also de-
pendent on the presence of extracellular Ca2+ (1.1 mM) and
largely abolished when it was omitted (Table 1). Addition-
ally, similar effects were observed for both the RBCs from
SCD patients and from healthy individuals (cf Figs. 5a
(HbSS)) and Fig. 6 (HbAA). In corresponding K+ flux mea-
surements, Zn2+ increased the deoxygenation-induced K+
influx from 0.59±0.14 to 1.02±0.13 mmol(l cells h)−1
(means ± S.E.M., n=3; p<0.002) thus almost doubling the
activity of the Psickle-like activity.
As negatively charged plasma proteins are likely to che-
late Zn2+, in the final series of experiments, the effect of Zn2+
was determined in RBCs (in this case from normal HbAA
individuals suspended in autologous plasma, Fig. 6). In these
experiments, PS exposure was measured in the absence and
presence of added Zn2+ (100 μM). In saline, as in Fig. 5a,
Zn2+ resulted in considerable PS exposure. In plasma, how-
ever, an increase in the percentage of RBCs showing PS
exposure remained modest even after 60 min of incubation.
Similar findings were observed with RBCs from SCD pa-
tients (data not shown).
Discussion
The present findings further define the Ca2+ entry step re-
sponsible for deoxygenation-induced PS exposure in RBCs





















Fig. 2 Effect of EIPA on deoxygenation-induced PS exposure in RBCs
from SCD patients. PS exposure is normalised to exposure in RBCs at
time 0, just before addition of EIPA, which was 2.8±0.8 % (indicated by
the dotted line), and after 30 and 60 min deoxygenation in the absence
(solid black histograms) or presence (lighter histograms) of EIPA at 10,
50 and 100 μM. Data represent means ± S.E.M., n=5. All N.S. com-
pared to deoxygenated RBCs in the absence of EIPA
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stilbenes, SITS and DIDS and the pyrimidine derivative
dipyridamole) were similarly active against PS externalisa-
tion. By contrast, modulators of other pathways (including
inhibitors of the non-specific cation channel and agonists or
blockers of glutamate- and benzodiazepine-gated channels)
were without effect. Heavy metals Zn2+ and Gd3+, rather
than inhibiting PS exposure, caused increased levels of ex-
ternalisation, an effect which in the case of Zn2+ was shown
to be Ca2+ dependent but independent of oxygen tension,
HbS polymerisation and RBC sickling.
RBCs from SCD patients have been known to show
increased solute permeability for over 50 years. Seminal
experiments by Tosteson and colleagues showed that deox-
ygenated RBCs from SCD patients lost K+ at greater rates
than they gained Na+, resulting in net solute loss and shrink-
age [65]. This is particularly important as the lag time to HbS
polymerisation following deoxygenation is inversely propor-
tional to a very high power of the concentration of HbS [20].
Modest dehydration will markedly increase the likelihood of
sickling as RBCs traverse hypoxic areas of the vasculature.
Since then, the nature of the altered permeability has been
much studied and several pathways have been identified [23,
31, 46]. Amongst these are the KCl cotransporter (likely
KCC1 and KCC3 isoforms) and the Ca2+-activated K+ chan-
nel (or Gardos channel). In addition to increased permeabil-
ity to univalent cations, RBCs from SCD patients also show
elevated permeability to both Ca2+ and Mg2+ [21, 55, 58].
The pathway(s) responsible for passage of these ions remains
less certain, but a pre-eminent role for the deoxygenation-
induced cation conductance termed Psickle has been proposed
[31, 46].
Although the permeability characteristics of Psickle have
been extensively investigated, its molecular identity remains
enigmatic [31, 32]. As a flux pathway, its activation is
associated with deoxygenation, HbS polymerisation and
RBC shape change [31, 53, 58]. It is permeable to both
univalent and divalent cations including Ca2+, shows a dis-




























































Fig. 3 Effect of modulators of novel RBC cation channels on PS
exposure in RBCs from SCD patients. a PS exposure is normalised to
exposure in RBCs at time 0, just before addition of diazepam, which
was 5.3±1.0 % (indicated by the dotted line), and after 30 and 60 min
deoxygenation in the absence (solid black histograms) or presence
(lighter histograms) of diazepam at 10, 50 and 100 μM. Data represent
means ± S.E.M., n=6. All N.S. compared to deoxygenated RBCs in the
absence of diazepam. b PS exposure is normalised to exposure in RBCs
at time 0, just before addition of PK11195, which was 3.0±0.5 %
(indicated by the dotted line), and after 30 and 60 min deoxygenation
in the absence (solid black histograms) or presence (lighter histograms)
of PK11195 at 10, 50 and 100 μM. Data represent means ± S.E.M.,
n=7. All N.S. compared to deoxygenated RBCs in the absence of
PK11195. c PS exposure is normalised to exposure in oxygenated
RBCs at time 0, just before addition of NMDA or homocysteine, which
was 4.0±0.9 % (indicated by the dotted line), and after 30 and 60 min of
incubation in the absence (black histograms) or presence (lighter histo-
grams) of NMDA or homocysteine (both 100 μM). Data represent
means ± S.E.M., n=6. All N.S. compared to oxygenated RBCs in the
absence of NMDA or homocysteine
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and appears randomly (or “stochastically”) activated upon
deoxygenation [47]. As for its molecular nature, identifica-
tion of specific inhibitors has proved elusive. Stilbenes [30]
and dipyridamole [33], however, are partial inhibitors, with
the latter having been used in clinical trials [12].
Deoxygenation of RBCs from SCD patients is known to
result in increased PS exposure [6, 49, 66]. The effect is Ca2+
dependent, requiring physiological levels of extracellular
Ca2+ and elevation of intracellular Ca2+ to low micromolar
levels [66]. Psickle is therefore an obvious candidate for
mediation of Ca2+ entry with subsequent PS exposure fol-
lowing from inhibition of the aminophospholipid translocase
(or flippase) and stimulation of the RBC scramblase—both
now known to occur at low micromolar [Ca2+] [5, 66].
Notwithstanding, various other RBC cation pathways have
been described [35] and it is possible that one or more of
these are also involved.
The present results support a role for the Psickle-like pathway
in deoxygenation-induced PS exposure. Thus, stilbene deriva-
tives and dipyridamole were active against deoxygenation-
induced PS exposure, with no effect onmorphological sickling
(as also observed previously [30]) implying that they do not act
via reduction in HbS polymerisation and subsequent RBC
shape change. Inhibition by DIDS, in particular, occurred at
low concentrations (IC50 118 nM), more similar to those
required to inhibit anion flux through the anion exchanger
AE1, rather than monovalent cation flux through the Psickle
pathway described previously [30]. Altered AE1 behaviour
has been postulated to play a role in the conductance of
deoxygenated sickle cells [46] and has been shown to mediate
a cation permeability [11] or alter the activity of other cation
transporters [8], at least when mutated, which may be relevant
to the present findings. DIDS may also directly inhibit the
scrambling transporter, as well as Ca2+ entry, but this occurs
at much lower affinity with an IC50 of about 10 μM [37]. Here,
250 nM reduced PS exposure during deoxygenation to oxy-
genated levels.
By contrast, none of the other channel inhibitors/agonists,




















Fig. 4 Effect of streptomycin on deoxygenation-induced PS exposure
in RBCs from SCD patients. PS exposure is normalised to exposure in
RBCs at time 0, just before addition of streptomycin, which was
5.7±0.8 % (indicated by the dotted line), and after 30 and 60 min
deoxygenation in the absence (solid black histograms) or presence
(lighter histograms) of streptomycin at 10, 50 and 100 μM. Data
represent means ± S.E.M., n=9. All N.S. compared to deoxygenated



















































Fig. 5 Effect of heavy metals, Zn2+ and Gd3+, on deoxygenation-
induced PS exposure in RBCs from SCD patients. a PS exposure at
time 0, just before addition of Zn2+, was 3.8±0.4 % (indicated by the
dotted line), and is also shown after 30 and 60 min deoxygenation in the
absence (solid black histograms) or presence (lighter histograms) of
Zn2+ at 10, 50 and 100 μM. Data represent means ± S.E.M., n=7.
#p<0.001, +p<0.03 compared to deoxygenated RBCs in the absence of
Zn2+. b PS exposure at time 0, just before addition of Gd3+, was
3.5±0.6 % (indicated by the dotted line), and is also shown after 30
and 60 min deoxygenation in the absence (solid black histograms) or
presence (lighter histograms) of Gd3+ at 10, 25 and 50 μM. Data
represent means ± S.E.M., n=5. #p<0.002, +p<0.02 compared to
deoxygenated RBCs in the absence of Gd3+
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channel [2, 3, 27] or for the more controversial PBR- and
glutamate-gated pathways [9, 51], had any effect. Strepto-
mycin, which might act as a stretch-activated channel
blocker [13, 60], was also without effect.
Zn2+ and Gd3+, which also inhibit the cation conductance
of RBCs from SCD patients [10, 50], did not inhibit PS
exposure. Instead, they caused greatly increased levels of
externalisation—an effect previously described for Zn2+ in
RBCs from normal individuals following longer term (24 h)
exposure [38]. This was not dependent on oxygen tension
and appears to be mediated via a different mechanism than
the deoxygenation-induced PS exposure under study. Their
stimulation also required extracellular Ca2+, as described
previously [38]. It would appear that both destabilise the
RBC permeability, in a similar way to that described previ-
ously for lead and aluminium [45]. A possible action is via
titration of the surface negative charges. K+ influx measure-
ments, however, also showed a rise in the activity of Psickle-
like pathway which may also provide increased entry of Ca2+
for PS scrambling. Notwithstanding, experiments in plasma
suggest that chelation of Zn2+ would reduce its free concen-
tration below values required for the rapid PS exposure
described here. This effect may be of some significance as
some SCD patients are Zn2+ deficient and supplementation is
sometimes given [56, 57]. Ensuring that free plasma [Zn2+]
does not rise excessively is an obvious caveat in these cases.
Finally, although the present work is concerned with Ca2+
entry and deoxygenation-induced PS exposure in RBCs
from SCD patients, it is also important to note that in RBCs
from normal individuals other pathways may be significant.
In this context, it is important to note that the present results
concern RBCs from SCD patients whose permeability is
altered by the presence of polymerised HbS. Most previous
reports on PS exposure have been carried out on RBCs from
normal individuals (e.g. [44]). It is likely that Ca2+ entry,
which triggers subsequent PS exposure, can occur via sev-
eral different routes. Thus, in addition to the Psickle pathway
of sickle cells, normal RBCs show marked Ca2+ elevation in
response to lysophosphatidic acid [54, 63, 68], possibly via
the non-selective cation channel [35, 36, 44]. An alternative
Table 1 Effect of Zn2+ on phosphatidylserine (PS) exposure in red
blood cells (RBCs) from patients with sickle cell disease. All RBCs
were incubated in low potassium-containing (LK) saline and treated
with Zn2+ (100 μM) for the duration indicated. Extracellular Ca2+ was
also present at 1.1 mM or omitted from saline (with addition of 2 mM
EGTA). RBCs were equilibrated with nitrogen (deoxygenated) or air
(oxygenated). PS exposures are given as percentage of positive cells.
Values represent means ± S.E.M. (n=4). Statistics show p values for
RBCs treated with Zn2+ compared to paired controls without Zn2+ or for
Zn2+-treated RBCs in the presence or absence of Ca2+
1.1 mM [Ca2+]o 0 mM [Ca
2+]o
Control 100 μM Zn2+ Control 100 μM Zn2+
Time of incubation (min) Mean ± S.E.M. Mean ± S.E.M. Student’s t test
vs control
Mean ± S.E.M. Mean ± S.E.M. Student’s t test
vs 1.1 mM [Ca2+]o
Deoxygenated conditions
0 4.1±1.4 4.5±1.4 4.7±1.4 4.1±1.4
30 5.2±1.4 45.9±10.9 p<0.02 5.8±1.1 6.6±1.8 p<0.02
60 7.9±1.4 53.0±13.6 p<0.02 7.1±1.0 10.5±4.2 p<0.01
Oxygenated conditions
0 3.3±0.6 6.2±1.4 4.4±1.0 4.9±1.4
30 3.8±0.8 52.7±18.2 p<0.05 5.1±1.2 8.1±3.3 p<0.04







Control (1.1mM Ca2+ LK)















Fig. 6 Effect of Zn2+ and autologous plasma on PS exposure in RBCs
from normal (HbAA) individuals. RBCs were incubated under oxygen-
ated conditions in LK saline (solid histograms) or in autologous plasma
(hatched histograms), in which case pH was maintained by flushing
with warm humidified CO2 (5 %). Percentage PS exposure is shown at
time 0, just before addition of Zn2+ (100 μM), and after 30 and 60 min.
Histograms represent means ± S.E.M., n=4 (paired samples). #p<0.008
compared to values in plasma
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pathway for PS exposure involving protein kinase C has also
been proposed [54, 63], as well as the Ca2+-mediated one.
The role of these pathways in RBCs from SCD patients
remains to be investigated; however, the lack of effect of
EIPA on deoxygenation-induced PS exposure argues against
the involvement of the non-specific cation channel.
In summary, we show that PS exposure in RBCs from
SCD patients is stimulated by deoxygenation, via a pathway
likely consistent with mediation via Psickle. Future experi-
ments will be aimed at establishing the molecular identity of
this pathway and the establishment of inhibitors with poten-
tial for clinical use.
Acknowledgments UMC is supported by a BBSRC studentship. We
also thank the British Heart Foundation and the Medical Research
Council for financial support for the work.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
1. Barber LA, Palascak MB, Joiner CH, Franco RS (2009)
Aminophospholipid translocase and phospholipid scramblase activi-
ties in sickle erythrocyte subpopulations. Br J Haematol 146:447–455
2. Bennekou P (1993) The voltage-gated non-selective cation channel
from human red cells is sensitive to acetylcholine. Biochim Biophys
Acta 1147:165–167
3. Bennekou P, Christophersen P (2003) Ion channels. In: Bernhardt I,
Ellory JC (eds) Red cell membrane in health and disease. Springer,
Berlin, pp 139–152
4. Bevers EM, Williamson PL (2010) Phospholipid scrambling: an
update. FEBS Lett 584:2724–2730
5. Bitbol M, Fellmann P, Zachowski A, Devaux PF (1987) Ion regula-
tion of phosphatidylserine and phosphatidylethanolamine outside-
inside translocation in human erythrocytes. Biochim Biophys Acta
904:268–282
6. Blumenfeld N, Zachowski A, Galacteros F, Beuzard Y, Devaux PF
(1991) Transmembrane mobility of phospholipids in sickle erythro-
cytes: effect of deoxygenation on diffusion and asymmetry. Blood
77:849–854
7. Boas FE, Forman L, Beutler JA (1998) Phosphatidylserine expo-
sure and red cell viability in red cell ageing and in hemolytic
anemia. Proc Natl Acad Sci USA 95, 3077-3081
8. Bogdanova A, Goede JS, Weiss E, Bogdanov N, Bennekou P,
Bernhardt I, Lutz HU (2010) Cryohydrocytosis: increased activity
of cation carriers in red cells from a patient with a band 3 mutation.
Haematologica 95:189–198
9. Bouyer G, Cueff A, Egée S, Kmiecik J,Maksimova Y, Glogowska E,
Gallagher PG, Thomas SL (2011) Erythrocyte peripheral benzodiaz-
epine receptor/voltage-dependent anion channels are upregulated by
Plasmodium falciparum. Blood 118:2305–2312
10. Browning JA, Robinson HC, Ellory JC, Gibson JS (2007)
Deoxygenation-induced non-electrolyte pathway in red cells from
sickle cell patients. Cell Physiol Biochem 19:165–174
11. Bruce LJ, Robinson HC, Guizouarn H, Borgese F, Harrison P, King
MJ, Goede JS, Coles SE, Gore DM, Lutz HU, Layton DM, Iolascon
A, Ellory JC, Stewart GW (2005) Monovalent cation leaks in
human red cells caused by single amino-acid substitutions in the
transport domain of the band 3 chloride-bicarbonate exchanger,
AE1. Nat Genet 37:1258–1263
12. Charneski L, Congdon HB (2010) Effects of antiplatelet and anti-
coagulant medications on the vasoocclusive and thrombotic com-
plications of sickle cell disease: a review of the literature. Am J
Health Syst Pharmacol 67:895–900
13. Dalibalta S, Ellory JC, Browning JA, Wilkins RJ, Rees DC, Gibson
JS (2010) Novel permeability characteristics of red blood cells from
sickle cell patients. Blood Cells Mol Dis 45:46–52
14. Dasgupta SK, Guchhait P, Thiagarajan P (2006) Lactadherin binding
and phosphatidylserine expression on a cell surface—comparison
with annexin A5. Transl Res 148:19–25
15. Dasgupta SK, Thiagarajan P (2005) The role of lactadherin in the
phagocytosis of phosphatidylserine-expressing sickle red blood
cells by macrophages. Haematologica 90:1267–1268
16. Davies IJT, Musa M, Dormandy TL (1968) Measurements of
plasma zinc. J Clin Pathol 21:359–365
17. de Jong K, Larkin SK, Styles LA, Bookchin RM, Kuypers FA
(2001) Characterization of the phosphatidylserine-exposing sub-
populations of sickle cells. Blood 98:860–867
18. Dunham PB, Ellory JC (1981) Passive potassium transport in low
potassium sheep red cells: dependence upon cell volume and chlo-
ride. J Physiol 318:511–530
19. Duranton SM, Huber SM, Lang F (2002) Oxidation induces a Cl-
dependent cation conductance in human red blood cells. J Physiol
539:847–855
20. Eaton JW, Hofrichter J (1987) Hemoglobin S gelation and sickle
cell disease. Blood 70:1245–1266
21. Etzion Z, Tiffert T, Bookchin RM, Lew VL (1993) Effects of deox-
ygenation on active and passive Ca2+ transport and on the cytoplas-
mic Ca2+ levels of sickle cell anemia red cells. J Clin Investig
92:2489–2498
22. Franck PFH, Bevers EM, Lubin BH, Comfurius P, Chiu DT-Y, Op
den Kamp JAF, Zwaal RF, van Deenen LLM, Roelofsen B (1985)
Uncoupling of the membrane skeleton from the lipid bilayer. J Clin
Investig 75:183–190
23. Gibson JS (2001) Oxygen-sensitive cation transport in sickle cells.
Blood Cells Mol Dis 27:112–120
24. Gibson JS, Khan A, Speake PF, Ellory JC (2001) O2 dependence of
K+ transport in sickle cells: the effects of different cell populations
and the substituted benzaldehyde, 12C79. FASEB J 15:823–832
25. Haest CWM (2003) Distribution and movement of membrane
lipids. In: Bernhardt I, Ellory JC (eds) Red cell membrane transport
in health and disease. Springer, Berlin, pp 1–25
26. Haest CWM, Plasa G, Kamp D, Deuticke B (1978) Spectrin as a
stabilizer of the phospholipid asymmetry in the human erythrocyte
membrane. Biochim Biophys Acta 509:21–32
27. Halperin JA, Brugnara C, Tosteson MT, Van Ha T, Tosteson DC
(1989) Voltage-activated cation channels in human erythrocytes.
Am J Physiol 257:C986–C996
28. Halsted JA, Smith JC (1970) Plasma-zinc in health and disease.
Lancet 1(7642):322–324
29. Hebbel RP (1991) Beyond hemoglobin polymerization: the red
blood cell membrane and sickle cell disease pathophysiology.
Blood 77:214–237
30. Joiner CH (1990) Deoxygenation-induced cation fluxes in sickle
cells: II. Inhibition by stilbene disulfonates. Blood 76:212–220
31. Joiner CH (1993) Cation transport and volume regulation in sickle
red blood cells. Am J Physiol 264:C251–C270
32. Joiner CH, DewA, Ge DL (1988) Deoxygenation-induced fluxes in
sickle cells. I. Relationship between net potassium efflux and net
sodium influx. Blood Cells 13:339–348
33. Joiner CH, Jiang M, Claussen WJ, Roszell NJ, Yasin Z, Franco RS
(2001) Dipyridamole inhibits sickling-induced cation fluxes in
sickle red blood cells. Blood 97:3976–3983
Pflugers Arch - Eur J Physiol (2013) 465:1651–1660 1659
34. Joiner CH, Morris CL, Cooper ES (1993) Deoxygenation-induced
cation fluxes in sickle cells. III. Cation selectivity and response to
pH and membrane potential. Am J Physiol 264:C734–C744
35. Kaestner L (2011) Cation channels in erythrocytes—historical and
future perspective. Open Biol J 4:27–34
36. Kaestner L, Tabellion W, Lipp P, Bernhardt I (2004) Prostaglandin
E2 activates channel-mediated calcium entry in human erythro-
cytes: an indication of a blood clot formation supporting process.
Thromb Haemost 92:1269–1272
37. Kamp D, Sieberg T, Haest CWM (2001) Inhibition and stimulation
of phospholipid scrambling activity. Consequences for lipid
asymmetry, echinocytosis, and microvesiculation of erythrocytes.
Biochemistry 40:9438–9446
38. Kiedaisch V, Akel A, Niemoeller OM,Wieder T, Lang F (2008) Zinc-
induced suicidal erythrocyte death. Am J Clin Nutr 87:1530–1534
39. Kirk K (2001) Membrane transport in the malaria-infected eryth-
rocyte. Physiol Rev 81:495–537
40. Kuypers FA (2008) Red cell membrane lipids in hemoglobinopa-
thies. Curr Mol Med 8:633–638
41. Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD,
Lubin BH (1996) Detection of altered membrane phospholipid
asymmetry in subpopulations of human red blood cells using fluo-
rescently labeled annexin V. Blood 87:1179–1187
42. Lang F, Lang KS, Lang PA, Huber SM, Wieder T (2006)
Mechanisms and significance of eryptosis. Antioxid Redox Signal
8:1183–1192
43. Lang F, Lang KS, Wieder T, Myssina S, Birka C, Lang PA, Kaiser
S, Kempe DS, Duranton C, Huber SM (2003) Cation channels, cell
volume and the death of an erythrocyte. Eur J Physiol 447:121–125
44. Lang KS, Myssina S, Tanneur V, Wieder T, Huber SM, Lang F,
Duranton C (2003) Inhibition of erythrocyte cation channels and
apoptosis by ethylisopropylamiloride. Naunyn Schmiedebergs
Arch Pharmacol 367:391–396
45. Lang E, Qadri SM, Lang F (2012) Killing me softly—suicidal
erythrocyte death. Int J Biochem Cell Biol 44:1236–1243
46. Lew VL, Bookchin RM (2005) Ion transport pathology in the
mechanism of sickle cell dehydration. Physiol Rev 85:179–200
47. Lew VL, Ortiz OE, Bookchin RM (1997) Stochastic nature and red
cell population distribution of the sickling-induced Ca2+ permeabil-
ity. J Clin Investig 99:2727–2735
48. Lindeman RD, ClarkML, Colmore JP (1971) Influence of age and sex
on plasma and red-cell zinc concentrations. J Gerontol 26:358–363
49. Lubin B, Chiu D, Bastacky J, Roelofsen B, Van Deenen LLM
(1981) Abnormalities in membrane phospholipid organization in
sickled erythrocytes. J Clin Investig 67:1643–1649
50. Ma Y-L, Rees DC, Gibson JS, Ellory JC (2012) The conductance of
red blood cells from sickle cell patients: ion selectivity and in-
hibitors. J Physiol 590:2095–2105
51. Makhro A, Wang J, Vogel J, Boldyrev AA, Gassman M, Kaestner
L, Bogdanova A (2010) Functional NMDA receptors in rat eryth-
rocytes. Am J Cell Physiol 298:C1315–C1325
52. Middelkoop E, Lubin B, Bevers EM, Op den Kamp JA, Comfuriius
B, Chiu DT, Zwaal RF, van Deenen LLM, Roelofsen B (1988)
Studies on sickle erythrocytes provide evidence that the asymmetric
distribution of phosphatidylserine in the red cell membrane is
maintained by both ATP-dependent translocation and interaction with
membrane skeletal proteins. Biochim Biophys Acta 937:281–288
53. Mohandas N, Rossi ME, Clark MR (1986) Association between
morphologic distortion of sickle cells and deoxygenation-induced
cation permeability increases. Blood 68:450–454
54. Nguyen DB, Wagner-Britz L, Maia S, Steffen P, Wagner C,
Kaestner L, Bernhardt I (2011) Regulation of phosphatidylserine
exposure in red blood cells. Cell Physiol Biochem 28:847–856
55. Ortiz OE, Lew VL, Bookchin RM (1990) Deoxygenation
permeabilizes sickle cell anaemia red cells to magnesium and re-
verses its gradient in the dense cells. J Physiol 427:211–226
56. Prasad AS (2002) Zinc deficiency in patients with sickle cell
disease. Am J Clin Nutr 75:181–182
57. Reed JD, Redding-Lallinger R, Orringer EP (1987) Nutrition and
sickle cell disease. Am J Hematol 24:441–455
58. Rhoda MD, Apovo M, Beuzard Y, Giraud F (1990) Ca2+ perme-
ability in deoxygenated sickle cells. Blood 75:2453–2458
59. Setty BN, Kulkarini S, Stuart MJ (2002) Role of erythrocyte
phosphatidylserine in sickle red cell-endothelial adhesion. Blood
99:1564–1571
60. Shen M-R, Chou C-Y, Chiu WT (2003) Streptomycin and its
analogues are potent inhibitors of the hypotonicity-induced Ca2+
entry and Cl− channel activity. FEBS Lett 554:494–500
61. Shi J, Gilbert GE (2003) Lactadherin inhibits enzyme complexes of
blood coagulation by competing for phospholipid-binding sites.
Blood 101:2628–2636
62. Speake PF, Roberts CA, Gibson JS (1997) Effect of changes in
respiratory blood parameters on equine red blood cell K-Cl
cotransporter. Am J Physiol 273:C1811–C1818
63. Steffen P, Jung A, Nguyen DB, Muller T, Bernhardt I, Kaestner L,
Wagner C (2011) Stimulation of human red blood cells leads to
Ca2+-mediated intracellular adhesion. Cell Calcium 50:54–61
64. Stuart MJ, Setty BN (2001) Hemostatic alterations in sickle cell
disease: relationships to disease pathophysiology. Pediatr Pathol
Mol Med 20:27–46
65. Tosteson DC, Carlsen E, Dunham ET (1955) The effects of sickling
on ion transport. I. Effect of sickling on potassium transport. J Gen
Physiol 39:31–53
66. Weiss E, Cytlak UM, Rees DC, Osei A, Gibson JS (2012)
Deoxygenation-induced and Ca2+-dependent phosphatidylserine
externalisation in red blood cells from normal individuals and
sickle cell patients. Cell Calcium 51:51–56
67. Wood BL, Gibson DF, Tait JF (1996) Increased erythrocyte
phosphatidylserine exposure in sickle cell disease: flow-cytometric
measurement and clinical associations. Blood 88:1873–1880
68. Yang L, Andrews DA, Low PS (2000) Lysophosphatidic acid opens
a Ca2+ channel in human erythrocytes. Blood 95:2420–2425
1660 Pflugers Arch - Eur J Physiol (2013) 465:1651–1660
